0001628280-22-030745.txt : 20221123
0001628280-22-030745.hdr.sgml : 20221123
20221123160404
ACCESSION NUMBER: 0001628280-22-030745
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20221121
FILED AS OF DATE: 20221123
DATE AS OF CHANGE: 20221123
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Donley Matthew Maxwell
CENTRAL INDEX KEY: 0001636642
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36421
FILM NUMBER: 221416314
MAIL ADDRESS:
STREET 1: 4520 EAST WEST HIGHWAY, 3RD FLOOR
CITY: BETHESDA
STATE: MD
ZIP: 20814
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Aurinia Pharmaceuticals Inc.
CENTRAL INDEX KEY: 0001600620
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: A0
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: #1203-4464 MARKHAM STREET
CITY: VICTORIA BC
STATE: A1
ZIP: V8Z 7X8
BUSINESS PHONE: 250-708-4272
MAIL ADDRESS:
STREET 1: #1203-4464 MARKHAM STREET
CITY: VICTORIA BC
STATE: A1
ZIP: V8Z 7X8
4
1
wf-form4_166923742713580.xml
FORM 4
X0306
4
2022-11-21
0
0001600620
Aurinia Pharmaceuticals Inc.
AUPH
0001636642
Donley Matthew Maxwell
#1203-4464 MARKHAM STREET
VICTORIA
A1
V8Z7X8
BRITISH COLUMBIA, CANADA
0
1
0
0
Ex VP, Internal Operations
Common Stock
2022-11-21
4
P
0
10000
4.66
A
27927
D
Includes 1,703 common stock of the Issuer acquired by the reporting person on May 31, 2022 pursuant to the Company's 2021 Employee Stock Purchase Plan.
/s/ Matthew Maxwell Donley
2022-11-23